Agilent Technologies (NYSE:A) Earnings Call Presentation

Agilent Advanced Therapeutics Click to Edit Master Title Style Strategic Growth in Specialty CDMO March 27, 2026 Click to edit Master subtitle style Safe harbor This presentation contains forward-looking statements (including, without limitation, statements on Agilent's (the "company" or "our") strategy, priorities, growth and growth opportunities, productivity, reinvestment, customer focus, evolving product mix, work environment and innovation plans; our revenue, revenue growth, operating margin and margin ...